Bulletin of the Korean Chemical Society

Korean Chemical Society (대한화학회)
권호 표지
DOI QR코드

DOI QR Code

Polymorphic Forms of Furosemide Characterized by THz Time Domain Spectroscopy

  • Ge, Min (Shanghai Institute of Applied Physics, Chinese Academy of Sciences) ;
  • Liu, Guifeng (Shanghai Institute of Applied Physics, Chinese Academy of Sciences) ;
  • Ma, Shihua (Shanghai Institute of Applied Physics, Chinese Academy of Sciences) ;
  • Wang, Wenfeng (Shanghai Institute of Applied Physics, Chinese Academy of Sciences)
  • Published : 2009.10.20
Download PDF
⟨ Previous Next ⟩

Abstract

Terahertz time domain spectroscopy (THz-TDS) is applied in transmission to identify the five forms of modifications of furosemide and one commercial product from 0.3 THz to 1.6 THz at room temperature. The different absorption spectra of the different forms are sensitive to crystal structures. Density function theory (DFT) calculation was used to understand the vibrational modes of furosemide in the THz region. X-ray powder diffractometry (XRPD) was applied to confirm the different forms of modifications. The results demonstrate that THz-TDS is a potential analytical technique in investigating polymorphic forms in the pharmaceutical fields.

Keywords

References

  1. Haleblian, J. K.; McCrone, W. J. J. Pharm. Sci. 1969, 58, 911. https://doi.org/10.1002/jps.2600580802
  2. Trelfall, T. L. Analyst 1995, 120, 2435. https://doi.org/10.1039/an9952002435
  3. Brittain, H. G.; Bogdanowich, S. J.; Bugay, D. E.; DeVincentis, J.; Lewen, G.; Newman, A. W. Pharm. Res. 1991, 8, 963. https://doi.org/10.1023/A:1015888520352
  4. Byrn, S.; Pfeiffer, R.; Ganey, M.; Hoiberg, C.; Poochikian, G. Pharm. Res. 1995, 12, 945. https://doi.org/10.1023/A:1016241927429
  5. Yu, L.; Reutzel, S. M.; Stephenson, G. A. Pharmaceut. Sci. Tech. Today 1998, 1, 118. https://doi.org/10.1016/S1461-5347(98)00031-5
  6. Caira, M. R. Top. Curr. Chem. 1998, 198, 163. https://doi.org/10.1007/3-540-69178-2_5
  7. Brittain, H. G. J. Pharm. Sci. 1997, 86, 405. https://doi.org/10.1021/js960238e
  8. Tonouchi, M. Nat. Photonics 2007, 1, 97. https://doi.org/10.1038/nphoton.2007.3
  9. Tadday, P. F.; Bradley, I. V.; Arnone, D. D.; Pepper, M. J. Pharm. Sci. 2003, 92, 831. https://doi.org/10.1002/jps.10358
  10. Strachan, C. J.; Rades, T.; Newnham, D. A.; Gordon, K. C.; Pepper, M.; Taday, P. F. Chem. Phys. Lett. 2004, 390, 20. https://doi.org/10.1016/j.cplett.2004.03.117
  11. Strachan, C. J.; Taday, P. F.; Newnham, D. A.; Gordon, K. C.; Zeitler, J. A.; Pepper, M.; Rades, T. J. Pharm. Sci. 2005, 94, 837. https://doi.org/10.1002/jps.20281
  12. Zeitler, J. A.; Newnham, D. A.; Taday, P. F.; Strachan, C. J.; Pepper, M.; Gordon, K. C.; Rades, T. Thermochimica Acta 2005, 436, 71. https://doi.org/10.1016/j.tca.2005.07.006
  13. Fitzgerald, A. J.; Cole, B. E.; Taday, P. F. J. Pharm. Sci. 2004, 94, 177. https://doi.org/10.1254/jphs.94.177
  14. Liu, H. B.; Chen, Y.; Zhang, X. C. J. Pharm. Sci. 2007, 92, 927.
  15. Matsuda, Y.; Tatsumi, E. Int. J. Pharm. 1990, 60, 11. https://doi.org/10.1016/0378-5173(90)90185-7
  16. Liu, G. F.; Ma, X. J.; Ma, S. H.; Zhao, H. W.; Ma, M. W.; Ge, M.; Wang, W. F. Chin. J. Chem. 2008, 26, 1257. https://doi.org/10.1002/cjoc.200890228
  17. Day, G. M.; Zeitler, J. A.; Jones, W.; Rades, T.; Taday, P. F. J. Phys. Chem. B 2006, 110, 447. https://doi.org/10.1021/jp055439y
  18. Fischer, B. M.; Walther, M.; Jepsen, P. U. Phys. Med. Biol. 2003, 47, 3807. https://doi.org/10.1088/0031-9155/47/21/319
  19. Shen, Y. C.; Upadhya, P. C.; Linfield, E. H.; Davies, A. G. Appl. Phys. Lett. 2003. 82, 2350. https://doi.org/10.1063/1.1565680
  20. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B. et al. Gaussian 03, Revision C.02; Gaussian, Inc.: Wallingford CT, 2004.
  21. Doherty, C.; York, P. J. Pharm. Sci. 1987, 76, 731. https://doi.org/10.1002/jps.2600760912
  22. Doherty, C.; York, P. Int. J. Pharm. 1988, 47, 141. https://doi.org/10.1016/0378-5173(88)90225-6

Cited by

  1. High solubility crystalline hydrates of Na and K furosemide salts vol.16, pp.22, 2014, https://doi.org/10.1039/C3CE42347F
  2. Novel furosemide cocrystals and selection of high solubility drug forms vol.101, pp.2, 2009, https://doi.org/10.1002/jps.22805
  3. Optical properties of Meloxicam in the far-infrared spectral region vol.512, pp.None, 2009, https://doi.org/10.1016/j.chemphys.2018.04.022
  4. Characteristic terahertz absorption spectra of paramylon and paramylon-ester compounds vol.244, pp.None, 2009, https://doi.org/10.1016/j.saa.2020.118828